Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy

Affiliations

• ¹ Stanford University Medical Center, Stanford, CA.
• ² University of Maryland School of Medicine-Greenebaum Comprehensive Cancer Center, Baltimore, MD.
• ³ Moffitt Cancer Center, Tampa, FL.
• ⁴ The University of Texas MD Anderson Cancer Center, Houston, TX.
• ⁵ Washington University School of Medicine and Siteman Cancer Center, St Louis, MO.
• ⁶ Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
• ⁷ University of Nebraska Medical Center, Omaha, NE.
• ⁸ University of Miami Miller School of Medicine, Miami, FL.
• ⁹ University of Rochester Medical Center, Rochester, NY.
• ¹⁰ Vanderbilt-Ingram Cancer Center, Nashville, TN.
• ¹¹ University of Kansas Medical Center, Kansas City, KS.
• ¹² Karmanos Center Institute/Wayne State University, Detroit, MI.
• ¹³ John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ.
• ¹⁴ Division of Hematology/Oncology, Department of Medicine, University of California San Francisco Medical Center, San Francisco, CA.
• ¹⁵ Banner MD Anderson Cancer Center, Gilbert, AZ.
• ¹⁶ UPMC Hillman Cancer Center, Pittsburgh, PA; and.
• ¹⁷ Division of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH.